Comparison of the Effect of Hydrophobic Acrylic and Silicone 3-piece IOLs on Posterior Capsule Opacification
1 other identifier
interventional
50
1 country
1
Brief Summary
Age-related cataract is the main cause of impaired vision in the elderly population worldwide. The only treatment that can restore functional visual ability is cataract surgery where the opacified crystalline lens is removed by phacoemulsification and an artificial intraocular lens is implanted into the remaining capsular bag. Cataract operations are generally very successful, with a low risk of serious complications. The most common reason for impaired vision after uneventful cataract surgery in otherwise healthy eyes is the development of posterior capsule opacification (PCO). PCO is a physiological change (thickening, opacification and clouding) of the capsular bag expected after cataract surgery, because the lens epithelial cells (LECs) undergo hyperplasia and cellular migration. PCO is treated with Nd:YAG capsulotomy, a quick outpatient procedure that uses a laser to open a central hole in the posterior capsular bag. Modifications in IOL design and material lead to a decrease in the incidence of PCO. During the past two decades, refinements in surgical technique were made resulting in today's small incision phacoemulsification surgery. Nowadays a multitude of microincision IOLs are available, many of them similar but of course with some differences in regard to the chemical composition of the acrylic material and the IOL design. The purpose of this study is to compare the development of posterior capsule opacification (PCO) and the frequency of treatment between two different microincision IOLs over a period of 2 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2011
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 3, 2013
CompletedFirst Posted
Study publicly available on registry
September 6, 2013
CompletedSeptember 6, 2013
September 1, 2013
Same day
September 3, 2013
September 5, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
posterior capsular opacification (PCO)
subjective and objective PCO scoring
2 xears
Secondary Outcomes (2)
best corrected visual acuity (BCVA)
2 years
Nd:YAG rate
2 years
Study Arms (2)
acrylic 3-piece IOL
OTHERsame-day bilateral cataract surgery with implantation of intraocular lens Domilens KS-XS in one eye
silicone 3-piece IOL
OTHERsame-day bilateral cataract surgery with implantation of intraocular lens Domilens KS-3Ai in one eye
Interventions
same-day bilateral cataract surgery with implantation of intraocular lens
Eligibility Criteria
You may qualify if:
- bilateral age-related cataract
- good overall physical constitution
You may not qualify if:
- previous intraocular surgery or ocular trauma
- intraocular complication like posterior capsular tear
- glaucoma
- uveitis
- corneal diseases, diabetic retinopathy and any other severe retinal -pathology that would make a postoperative visual acuity of 20/40 (decimal equivalent = 0.5) or better unlikely
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Ophthalmology and Optometry of the Medical University Vienna
Vienna, Vienna, 1090, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ao.Univ.-Prof. Dr.med.univ.
Study Record Dates
First Submitted
September 3, 2013
First Posted
September 6, 2013
Study Start
March 1, 2011
Primary Completion
March 1, 2011
Study Completion
August 1, 2011
Last Updated
September 6, 2013
Record last verified: 2013-09